Schellenberg, Kerri L

A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS

Andrews, Jinsy , Genge, Angela , Jackson, Carlayne E. , Miller, Timothy M. , Cockroft, Bettina M., Meng, Lisa , Wei, Jenny , Wolff, Andrew A. , Malik, Fady I. , Bodkin, Cynthia, Dionne, Annie , Fee, Dominic B. , Goutman, Stephen A. , Goyal, Namita , Hardiman, Orla , Hayat, Ghazala , Heiman‐Patterson, Terry , Heitzman, Daragh, Johnston, Wendy , Kiernan, Matthew C. , Korngut, Lawrence , Matte, Geneviève, Mora, Jesús S., Needham, Merrilee , Oskarsson, Björn , Pattee, Gary L. , Pulley, Michael , Quan, Dianna , Rezania, Kourosh , Schellenberg, Kerri , Schultz, David , Shoesmith, Christen , Simmons, Zachary , Statland, Jeffrey , Sultan, Shumaila, Weiss, Michael D. , Whyte-Rayson, Ashley, Wymer, James , Zinman, Lorne , Rudnicki, Stacy A. , Oskarsson, Björn , Schellenberg, Kerri L , Goutman, Stephen A , Simmons, Zachary , Hardiman, Orla , Kiernan, Matthew C , Shefner, Jeremy M. , Lechtzin, Noah , Brooks, Benjamin Rix , Caress, James B. , Henderson, Robert D. , Karam, Chafic , Kolb, Stephen J. , Ladha, Shafeeq , Pioro, Erik P. , Swenson, Andrea , Berg, Leonard H. van den , Vu, Tuan , Vucic, Steve

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | September 24, 2020 | Volume: 22 | Issue: 3-4 | Pages: 287-299

10.1080/21678421.2020.1822410